HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more
This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim...
MIRAMAR, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 9.09090909091 | 0.55 | 0.6799 | 0.5498 | 13252 | 0.58787911 | CS |
4 | 0.089 | 17.4168297456 | 0.511 | 0.7037 | 0.4 | 31456 | 0.55783193 | CS |
12 | -0.178 | -22.8791773779 | 0.778 | 0.849999 | 0.4 | 17347 | 0.58964187 | CS |
26 | -0.9 | -60 | 1.5 | 1.93 | 0.4 | 18750 | 0.92335136 | CS |
52 | -1.45 | -70.7317073171 | 2.05 | 2.181 | 0.4 | 17248 | 1.14037508 | CS |
156 | -3.3 | -84.6153846154 | 3.9 | 7.05 | 0.4 | 278383 | 4.3686486 | CS |
260 | -6.9 | -92 | 7.5 | 7.51 | 0.4 | 270994 | 4.3907695 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.